Whole exome sequencing was performed on primary cultures of mouse lymphoma B cells derived from the lambda-MYC transgenic strain. WXS were performed on representative cases of lymphomas expressing the
To identify novel genetic characterizations involved in PD-L1/2, other immune checkpoints and other driver genes in DLBCL patients and to identify patients that would benefit from immunotherapies and